Detalles de la búsqueda
1.
Cost and burden of gastroesophageal reflux disease among patients with persistent symptoms despite proton pump inhibitor therapy: an observational study in France.
BMC Gastroenterol
; 13: 39, 2013 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-23448382
2.
The burden of disrupting gastro-oesophageal reflux disease: a database study in US and European cohorts.
Clin Drug Investig
; 30(3): 167-78, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20155989
3.
Objective measurement of work absence and on-the-job productivity: a case-control study of US employees with and without gastroesophageal reflux disease.
J Occup Environ Med
; 50(1): 25-31, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18188078
4.
Cost-effectiveness of Simple Insulin Infusion Devices Compared to Multiple Daily Injections in Uncontrolled Type 2 Diabetics in the United States Based on a Simulation Model.
J Health Econ Outcomes Res
; 6(1): 84-95, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-32685574
5.
The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD): responsiveness to change and English language validation.
Pharmacoeconomics
; 25(5): 385-96, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17488137
6.
The impact of illness in patients with moderate to severe gastro-esophageal reflux disease.
BMC Gastroenterol
; 5: 23, 2005 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-16004616
7.
Impact of once-daily extended-release quetiapine fumarate on hospitalization length in patients with acute bipolar mania.
J Comp Eff Res
; 4(1): 51-9, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25168473
8.
Cost effectiveness of esomeprazole compared with omeprazole in the acute treatment of patients with reflux oesophagitis in the UK.
Pharmacoeconomics
; 20(4): 279-87, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-11950384
9.
Cost effectiveness of proton pump inhibitors in gastro-oesophageal reflux disease without oesophagitis: comparison of on-demand esomeprazole with conventional omeprazole strategies.
Pharmacoeconomics
; 20(4): 267-77, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-11950383
10.
A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective.
Pharmacoeconomics
; 22(4): 225-44, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-14974873
11.
Impact of extended-release quetiapine fumarate on hospitalization length and cost in schizophrenia and bipolar disorder patients: a retrospective, hospital-based, US-cohort analysis.
J Comp Eff Res
; 3(4): 335-44, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25275231
12.
Partial response to proton pump inhibitor therapy for GERD: observational study of patient characteristics, burden of disease, and costs in the USA.
Pragmat Obs Res
; 3: 57-67, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-27774018
13.
Employers need to have a wider horizon than drug costs alone when considering the implementation of health care intervention programs.
J Manag Care Pharm
; 12(7): 581-2; author reply 582-3, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16981804
14.
Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD)--results from a cross-sectional study.
Value Health
; 5(2): 106-13, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-11918826
Resultados
1 -
14
de 14
1
Próxima >
>>